Shanghai Obio Technology (Group) (SHSE:688238) ROCE %: -12.35% (As of Mar. 2026)

What is Shanghai Obio Technology (Group) ROCE %?

Shanghai Obio Technology (Group) SHSE:688238 +1.29% 63 ROCE % is -12.35% as of Mar. 2026. GuruFocus rates SHSE:688238 with a GF Score™ of 63/100 and a GF Value™ of ¥7.77 (Possible Value Trap). The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Shanghai Obio Technology (Group)'s annualized ROCE % for the quarter that ended in Mar. 2026 was -12.35%.

Shanghai Obio Technology (Group) (SHSE:688238) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Shanghai Obio Technology (Group) ROCE % Related Terms

Shanghai Obio Technology (Group) ROCE % Historical Data

* Premium members only.

The historical data trend for Shanghai Obio Technology (Group)'s ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Obio Technology (Group) ROCE % Chart

Shanghai Obio Technology (Group) Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROCE %

Get a 7-Day Free Trial

6.19

2.58

-6.47

-14.38

-12.46

Shanghai Obio Technology (Group) Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROCE %	Get a 7-Day Free Trial															-12.23	-9.24	-12.87	-16.87	-12.35

63GF Score

Shanghai Obio Technology (Group) Corp Ltd SHSE:688238

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Shanghai Obio Technology (Group) ROCE % Calculation

Shanghai Obio Technology (Group)'s annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	-224.465	/	( ( (2284.741 - 329.891)	+	(2091.792 - 443.954) )	/ 2 )
	=	-224.465	/	( (1954.85	+	1647.838)	/ 2 )
	=	-224.465	/	1801.344
	=	-12.46 %

Shanghai Obio Technology (Group)'s ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	-202.348	/	( ( (2091.792 - 443.954)	+	(1998.178 - 368.906) )	/ 2 )
	=	-202.348	/	( ( 1647.838	+	1629.272 )	/ 2 )
	=	-202.348	/	1638.555
	=	-12.35 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of -12.35% mean?

Shanghai Obio Technology (Group) (SHSE:688238) has a ROCE % of -12.35% as of Mar. 2026.

Is Shanghai Obio Technology (Group)'s ROCE % too high?

Shanghai Obio Technology (Group)'s current ROCE % is -12.35%. Overall, Shanghai Obio Technology (Group) has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does Shanghai Obio Technology (Group)'s ROCE % compare to VRTX and REGN?

Shanghai Obio Technology (Group)'s ROCE % of -12.35% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Biotechnology company?

A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. Shanghai Obio Technology (Group)'s current ROCE % is -12.35%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Shanghai Obio Technology (Group) stock overvalued right now?

Based on GuruFocus' analysis, Shanghai Obio Technology (Group) (SHSE:688238) is currently considered Possible Value Trap. The stock's GF Value™ is ¥7.77, compared to a current price of ¥5.49 — trading 29.3% below its estimated fair value. The current ROCE % is -12.35%. Shanghai Obio Technology (Group)'s overall GF Score™ is 63/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Shanghai Obio Technology (Group) (SHSE:688238), the current ROCE % is -12.35% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Obio Technology (Group) (SHSE:688238) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Obio Technology (Group) stock appears to be undervalued. The current stock price of ¥5.49 is trading 29.3% below its estimated GF Value™ of ¥7.77. GuruFocus considers Shanghai Obio Technology (Group) to be Possible Value Trap.

Key valuation signals for SHSE:688238:

ROCE %: -12.35%
GF Value™: ¥7.77 vs. price of ¥5.49 (29.3% below fair value)
GF Score™: 63/100 with 5 warning signs

No single metric tells the full story. See the SHSE:688238 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai Obio Technology (Group) Business Description

Industry Healthcare Biotechnology

Comparable Companies SZSE:000518 SZSE:002286 SHSE:688302 SZSE:300404 SHSE:603566 SZSE:003020 SZSE:300318 SZSE:002868 SZSE:300238 SZSE:300966 VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Address Lane 908, Ziping Road, Building 19, International Medical Park, Pudong New Area, Shanghai, CHN, 201318

Website https://www.obiosh.com

Shanghai Obio Technology (Group) Corp Ltd provides contract research organization (CRO) services, including gene therapy vector development and gene function research for basic research, as well as contract development and manufacturing organization (CDMO) services, including IND-enabling CMC research and GMP production of clinical samples for gene therapy drug development.

63GF Score

Get the complete analysis for SHSE:688238

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥5.49

Price

¥7.77

GF Value

View SHSE:688238 Analysis

See ROCE % data for all stocks →